JP2006503006A5 - - Google Patents

Download PDF

Info

Publication number
JP2006503006A5
JP2006503006A5 JP2004526742A JP2004526742A JP2006503006A5 JP 2006503006 A5 JP2006503006 A5 JP 2006503006A5 JP 2004526742 A JP2004526742 A JP 2004526742A JP 2004526742 A JP2004526742 A JP 2004526742A JP 2006503006 A5 JP2006503006 A5 JP 2006503006A5
Authority
JP
Japan
Prior art keywords
compound
formula
alkenyl
alkyl
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004526742A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006503006A (ja
JP4598523B2 (ja
Filing date
Publication date
Priority claimed from DE10235624A external-priority patent/DE10235624A1/de
Application filed filed Critical
Publication of JP2006503006A publication Critical patent/JP2006503006A/ja
Publication of JP2006503006A5 publication Critical patent/JP2006503006A5/ja
Application granted granted Critical
Publication of JP4598523B2 publication Critical patent/JP4598523B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004526742A 2002-08-02 2003-07-18 喘息に使用するc−maf阻害剤としてのエンジアンドリック酸h誘導体 Expired - Fee Related JP4598523B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10235624A DE10235624A1 (de) 2002-08-02 2002-08-02 Endiandric acid H und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
PCT/EP2003/007821 WO2004014888A1 (de) 2002-08-02 2003-07-18 Endiandric acid h derivate als c-maf inhibitoren zur verwendung gegen asthma

Publications (3)

Publication Number Publication Date
JP2006503006A JP2006503006A (ja) 2006-01-26
JP2006503006A5 true JP2006503006A5 (https=) 2006-08-31
JP4598523B2 JP4598523B2 (ja) 2010-12-15

Family

ID=30469404

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004526742A Expired - Fee Related JP4598523B2 (ja) 2002-08-02 2003-07-18 喘息に使用するc−maf阻害剤としてのエンジアンドリック酸h誘導体

Country Status (13)

Country Link
US (1) US7019028B2 (https=)
EP (1) EP1529040B1 (https=)
JP (1) JP4598523B2 (https=)
AT (1) ATE314359T1 (https=)
AU (1) AU2003250099B2 (https=)
BR (1) BR0313199A (https=)
CA (1) CA2493483C (https=)
DE (2) DE10235624A1 (https=)
DK (1) DK1529040T3 (https=)
ES (1) ES2254980T3 (https=)
IL (1) IL166439A (https=)
MX (1) MXPA05000387A (https=)
WO (1) WO2004014888A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1944361A1 (en) 2007-01-11 2008-07-16 INSERM (Institut National de la Santé et de la Recherche Médicale) A method for expanding monocytes
CN108192972B (zh) 2010-10-06 2022-09-09 生物医学研究机构基金会 用于乳腺癌转移的诊断、预后和治疗的方法
EP2650682A1 (en) 2012-04-09 2013-10-16 Fundació Privada Institut de Recerca Biomèdica Method for the prognosis and treatment of cancer metastasis
BR112014030750A2 (pt) 2012-06-06 2017-08-22 Inst Catalana Recerca Estudis Avancats Método para diagnóstico, prognóstico e tratamento da metástase do câncer pulmonar
US10119171B2 (en) 2012-10-12 2018-11-06 Inbiomotion S.L. Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
ES2906586T3 (es) 2012-10-12 2022-04-19 Inbiomotion Sl Método para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de próstata
WO2015019125A1 (en) * 2013-08-05 2015-02-12 Societe De Developpement Et De Recherche Industrielle Molecular targets for the treatment of wounds, in particular chronic wounds
US11596642B2 (en) 2016-05-25 2023-03-07 Inbiomotion S.L. Therapeutic treatment of breast cancer based on c-MAF status
KR20200104298A (ko) 2017-11-22 2020-09-03 인바이오모션 에스.엘. c-MAF 상태에 기반한 유방암의 요법 치료

Similar Documents

Publication Publication Date Title
CN1066713C (zh) 茋衍生物和含有它们的药物组合物
JP2007501809A5 (https=)
EP2311851A3 (en) Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
JP2009143956A5 (https=)
JP2006503006A5 (https=)
US5045565A (en) Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain
JP2005536503A5 (https=)
RU2005121908A (ru) Производные зн-хиназолин-4-она
RU2008142527A (ru) Производные бупренорфина и их применение
US5099030A (en) Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain
JP2006510658A5 (https=)
JP2012518649A5 (https=)
RU2008152751A (ru) Соли тримебутина и n-десметилтримебутина
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина
CA2493483A1 (en) Endiandric acid h as c-maf inhibitors derivatives for use against asthma
FI89803C (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara substituerade silylalkylenaminer
JP2011516572A5 (https=)
DE602004030616D1 (de) Amlodipin-gentisat und verfahren zu dessen herstellung
RU2010141977A (ru) Циклическое соединение и его соль
CN1172908C (zh) N-取代苄基或苯基芳香磺酰胺化合物及其用途
RU98103460A (ru) Производные бензолсульфонамида, их получение и терапевтическое применение
RU2005125636A (ru) Производные бензоксазола и их применение в качестве лигандов рецептора аденозина
CN1649600A (zh) 氟西汀及类似物的糖醛酰胺、苷和原酸酯苷及其应用
JP2005506324A5 (https=)
RU2013133788A (ru) Производные глико-cf2-серина и глико-cf2-треонина